Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
PHSP-Net: Personalized Habitat-Aware Deep Learning for Multi-Center Glioblastoma Survival Prediction Using
Tianci Liu1, Yao Zheng1, Chengwei Chen1
1School of Biomedical Engineering, Air Force Medical University, No. 169 Changle West Road, Xi'an 710032, China.
Background:
Glioblastoma (GBM) is a highly aggressive and heterogeneous primary malignancy of the central nervous system, with a median overall survival (OS) of approximately 15 months. Achieving accurate and generalizable OS prediction across multi-center settings is essential for clinical application.
Methods:
We propose a Personalized Habitat-aware Survival Prediction Network (PHSP-Net) that integrates multiparametric MRI with an adaptive habitat partitioning strategy. The network combines deep convolutional feature extraction and interpretable visualization modules to perform patient-specific subregional segmentation and survival prediction. A total of 1084 patients with histologically confirmed WHO grade IV GBM from four centers (UPENN-GBM, UCSF-PDGM, LUMIERE and TCGA-GBM) were included. PHSP-Net was compared with conventional radiomics, habitat imaging models and ResNet10, with independent validation on two external cohorts.
Results:
PHSP-Net achieved an AUROC of 0.795 (95% CI: 0.731-0.852) in the internal validation set, and 0.707 and 0.726 in the LUMIERE and TCGA-GBM external test sets, respectively-outperforming both comparison models. Kaplan-Meier analysis revealed significant OS differences between predicted high- and low-risk groups (log-rank p < 0.05). Visualization analysis indicated that necrotic-region habitats were key prognostic indicators.
Conclusions:
PHSP-Net demonstrates high predictive accuracy, robust cross-center generalization and improved interpretability in multi-center GBM cohorts. By enabling personalized habitat visualization, it offers a promising non-invasive tool for prognostic assessment and individualized clinical decision making in GBM.
More Related Videos
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018